Pliant Therapeutics, Inc. · NASDAQ:PLRX

Citadel Advisors LLC's stake in Pliant Therapeutics, Inc. fell to 4.90% (Schedule 13G)

Event Jan 23, 2026 · Filed Jan 30, 2026

Citadel Advisors LLC's stake in Pliant Therapeutics, Inc. fell to 4.90%, 3,037,695 shares, as a passive investor on Jan 23, 2026. Filed Jan 30, 2026 (Schedule 13G).

Stake
4.90%
Shares
3,037,695
Intent
Passive
What changed
Fell below 5%
Filed together
7 holders

The filing in full

HolderStakeShares
Citadel Advisors LLC3.40%2,099,798
Citadel Advisors Holdings LP3.40%2,099,798
Citadel GP LLC3.40%2,099,798
Citadel Securities LLC1.50%909,171
Citadel Securities Group LP1.50%937,897
Citadel Securities GP LLC1.50%937,897
Kenneth Griffin4.90%3,037,695

Source

View original at SEC

Related